首页> 外国专利> PARENTERAL INTRAVENOUS AND PERORAL INTRODUCTION OF OXAZOLIDINONES FOR TREATMENT OF INFECTIOUS FOOT LESIONS IN DIABETES

PARENTERAL INTRAVENOUS AND PERORAL INTRODUCTION OF OXAZOLIDINONES FOR TREATMENT OF INFECTIOUS FOOT LESIONS IN DIABETES

机译:腹腔静脉和经口引入恶唑烷酮治疗糖尿病感染性足部病变

摘要

FIELD: medicine.;SUBSTANCE: claimed group of inventions relate to medicine, in particular to endocrinology and concerns treatment of infectious foot lesions in diabetes. For this purpose oxazolidinone antibiotic linezoide is introduced in efficient amount. Linezolide is able to penetrate into affected with diabetes tissues and accumulate in them in efficient amounts.;EFFECT: treatment of infection caused by antibiotic-resistant strains of microorganisms.;30 cl, 2 dwg, 3 ex, 4 tbl
机译:糖尿病感染性足部病变的治疗技术领域本发明要求保护的组涉及医学,尤其涉及内分泌学,并且涉及糖尿病中感染性足部病变的治疗。为此目的,引入有效量的恶唑烷酮抗生素利奈唑胺。利奈唑胺能够渗透到受糖尿病影响的组织中并有效地积累。效果:治疗由抗生素耐药菌株引起的感染; 30 cl,2 dwg,3 ex,4 tbl

著录项

  • 公开/公告号RU2354372C2

    专利类型

  • 公开/公告日2009-05-10

    原文格式PDF

  • 申请/专利权人 FARMATSIJA EHND APDZHON KOMPANI LLS;

    申请/专利号RU20040131830

  • 发明设计人 NORDEN KARL (US);

    申请日2003-03-21

  • 分类号A61K31/42;A61P31/04;

  • 国家 RU

  • 入库时间 2022-08-21 19:10:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号